Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight (SURMOUNT-2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04657003
Recruitment Status : Active, not recruiting
First Posted : December 7, 2020
Last Update Posted : April 19, 2022
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 20, 2023
Estimated Study Completion Date : April 17, 2023